| P50 | author | Nanna B. Finnerup | Q47814805 |
| P2093 | author name string | Cathrine Baastrup | |
| P2860 | cites work | Recommendations for the pharmacological management of neuropathic pain: an overview and literature update | Q24616897 |
| | Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21 | Q28240813 |
| | Laser-evoked potential abnormalities in central pain patients: the influence of spontaneous and provoked pain | Q31118439 |
| | The international spinal cord injury pain basic data set. | Q31157388 |
| | The CONECSI trial: results of a randomized controlled trial of a multidisciplinary cognitive behavioral program for coping with chronic neuropathic pain after spinal cord injury | Q82594639 |
| | Enhanced recovery of human spinothalamic function is associated with central neuropathic pain after SCI | Q83222717 |
| | Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience | Q83986754 |
| | Dendritic spine remodeling after spinal cord injury alters neuronal signal processing | Q84432492 |
| | A cross-sectional study of demographic and morphologic features of rotator cuff disease in paraplegic patients | Q84493787 |
| | Reflex and pain behaviors are not equivalent: Lessons from spinal cord injury | Q85122261 |
| | Reliability and validity of the International Spinal Cord Injury Basic Pain Data Set items as self-report measures. | Q33507240 |
| | Neuro magnetic resonance spectroscopy using wavelet decomposition and statistical testing identifies biochemical changes in people with spinal cord injury and pain | Q33624778 |
| | NeuPSIG guidelines on neuropathic pain assessment | Q33695540 |
| | Treatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain. | Q34064354 |
| | Effectiveness of transcranial direct current stimulation and visual illusion on neuropathic pain in spinal cord injury | Q34088645 |
| | EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision | Q34110857 |
| | International standards for neurological classification of spinal cord injury | Q34468648 |
| | Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. | Q34515061 |
| | Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial | Q34549363 |
| | Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis | Q34561157 |
| | Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. | Q34574367 |
| | Neuropathic pain: redefinition and a grading system for clinical and research purposes | Q34713765 |
| | Chronic spontaneous activity generated in the somata of primary nociceptors is associated with pain-related behavior after spinal cord injury | Q34777260 |
| | Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome. | Q34893944 |
| | Subarachnoid Transplant of the Human Neuronal hNT2.19 Serotonergic Cell Line Attenuates Behavioral Hypersensitivity without Affecting Motor Dysfunction after Severe Contusive Spinal Cord Injury | Q35103967 |
| | Conditioned place preference reveals tonic pain in an animal model of central pain | Q35132076 |
| | Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain | Q35175618 |
| | Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury | Q35296473 |
| | Treatments for chronic pain in persons with spinal cord injury: A survey study | Q35781122 |
| | Pain after spinal cord injury: an evidence-based review for clinical practice and research. Report of the National Institute on Disability and Rehabilitation Research Spinal Cord Injury Measures meeting | Q36276617 |
| | Sodium channel expression and the molecular pathophysiology of pain after SCI. | Q36873736 |
| | The role of cation-dependent chloride transporters in neuropathic pain following spinal cord injury | Q36922030 |
| | Effects of self-hypnosis training and EMG biofeedback relaxation training on chronic pain in persons with spinal-cord injury | Q37315136 |
| | Prevalence of chronic pain after traumatic spinal cord injury: a systematic review. | Q37522131 |
| | Neurogenic colorectal and pelvic floor dysfunction | Q37569083 |
| | The chronic neuropathic pain of spinal cord injury: which efficiency of neuropathic stimulation? | Q37631849 |
| | Chronic neuropathic pain in spinal cord injury: efficiency of deep brain and motor cortex stimulation therapies for neuropathic pain in spinal cord injury patients | Q37631852 |
| | GABA and central neuropathic pain following spinal cord injury | Q37826940 |
| | Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury | Q37851055 |
| | Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches | Q37858078 |
| | Spinal cord injury, dendritic spine remodeling, and spinal memory mechanisms | Q37933860 |
| | Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats | Q37950711 |
| | Are we neglecting spinal reorganization following nerve damage? | Q37959227 |
| | CCL2 is a key mediator of microglia activation in neuropathic pain states | Q38500555 |
| | A modified microsurgical DREZotomy procedure for refractory neuropathic pain | Q39265559 |
| | Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial | Q39276733 |
| | Levetiracetam in spinal cord injury pain: a randomized controlled trial. | Q39302571 |
| | Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports. | Q39308781 |
| | Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen | Q39331490 |
| | Types and effectiveness of treatments used by people with chronic pain associated with spinal cord injuries: influence of pain and psychosocial characteristics | Q39388981 |
| | Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial | Q39407952 |
| | The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury | Q39424415 |
| | Clinical feasibility for cell therapy using human neuronal cell line to treat neuropathic behavioral hypersensitivity following spinal cord injury in rats. | Q39836992 |
| | Phantom body pain in paraplegics: Evidence for a central “pattern generating mechanism” for pain | Q40522930 |
| | Pain classification following spinal cord injury: the utility of verbal descriptors. | Q40658244 |
| | Ionotropic glutamate receptors contribute to maintained neuronal hyperexcitability following spinal cord injury in rats | Q41431312 |
| | Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury | Q42080553 |
| | Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain | Q42870269 |
| | Spinal-, brainstem- and cerebrally mediated responses at- and below-level of a spinal cord contusion in rats: evaluation of pain-like behavior | Q42878263 |
| | Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study | Q42882281 |
| | Above-level mechanical hyperalgesia in rats develops after incomplete spinal cord injury but not after cord transection, and is reversed by amitriptyline, morphine and gabapentin | Q42950478 |
| | Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury | Q43034344 |
| | Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury | Q43199296 |
| | Abdominal pain in long-term spinal cord injury. | Q43350026 |
| | Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury? | Q43720031 |
| | Evoked potentials and quantitative thermal testing in spinal cord injury patients with chronic neuropathic pain | Q43813341 |
| | Lamotrigine in spinal cord injury pain: a randomized controlled trial | Q43969767 |
| | Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain after spinal cord injury | Q44026894 |
| | Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. | Q44076309 |
| | Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). | Q44562517 |
| | Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury | Q44846985 |
| | Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial | Q46068388 |
| | Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. | Q46453521 |
| | Life satisfaction in people with spinal cord injury during the first five years after discharge from inpatient rehabilitation | Q46563870 |
| | Spatiotemporal CCR1, CCL3(MIP-1α), CXCR4, CXCL12(SDF-1α) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain | Q46767997 |
| | Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury | Q46874887 |
| | Gabapentin suppresses spasticity in the spinal cord-injured rat. | Q46928230 |
| | A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury | Q47855465 |
| | Recordings of abnormal activity in patients with deafferentation and central pain | Q47943771 |
| | Brain circuitry underlying pain in response to imagined movement in people with spinal cord injury | Q48337460 |
| | Sensory function in spinal cord injury patients with and without central pain | Q48428448 |
| | Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial | Q48484274 |
| | Neuropathic pain in spinal cord injury: significance of clinical and electrophysiological measures | Q48551621 |
| | Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury | Q48818307 |
| | A longitudinal study of depression from 1 to 5 years after spinal cord injury. | Q48903519 |
| | Strengthening and optimal movements for painful shoulders (STOMPS) in chronic spinal cord injury: a randomized controlled trial | Q48919444 |
| | Characterization of chronic pain and somatosensory function in spinal cord injury subjects | Q49048174 |
| | A new definition of neuropathic pain | Q57987223 |
| | MRI in chronic spinal cord injury patients with and without central pain | Q60678603 |
| | Multidisciplinary cognitive behavioural pain management programmes for people with a spinal cord injury: design and implementation | Q60736167 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pain management | Q621261 |
| P304 | page(s) | 207-216 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Current Pain and Headache Reports | Q15761579 |
| P1476 | title | Spinal cord injury pain: mechanisms and management | |
| P478 | volume | 16 | |